Cours Albert Labs International Corp. OTC Markets
Actions
ALBLF
CA0127841041
Recherche biotechnologique et médicale
Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- USD | -.--% | -.--% | -.--% |
CA 2021 | - | CA 2022 | - | Capitalisation | 2,73 M 2,45 M |
---|---|---|---|---|---|
Résultat net 2021 | -1 M -897 k | Résultat net 2022 | -7 M -6,28 M | VE / CA 2021 * | - |
Trésorerie nette 2021 | 76,7 k 68,82 k | Trésorerie nette 2022 | 79,12 k 70,99 k | VE / CA 2022 | - |
PER 2021 * |
-
| PER 2022 |
-0,32
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 84,71% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Robert Kang
DFI | Director of Finance/CFO | - | - |
Chief Tech/Sci/R&D Officer | 61 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Michael Raymont
CEO | Chief Executive Officer | 74 | - |
Navchand Jagpal
COO | Chief Operating Officer | - | - |
Ravinder Kang
BRD | Director/Board Member | 58 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+32,81% | 52,73 Md | |
+36,98% | 39 Md | |
-8,70% | 38,52 Md | |
+25,29% | 30,38 Md | |
-11,17% | 26,39 Md | |
+10,13% | 26,08 Md | |
+43,71% | 14,15 Md | |
+33,60% | 12,6 Md | |
-6,34% | 11,51 Md |
- Bourse
- Actions
- Action ABRT
- Action ALBLF